July 31, 2023—Imeka, the leading neuroimaging company combining diffusion imaging and AIArtificial Intelligence to map white matterA large network of nerve fibers that communicate between different areas of the brain. microstructureMicrometer-scale tissue features of the brain., today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Advanced Neuro Diagnostic Imaging (ANDIAdvanced Neuro Diagnostic Imaging) quantitative imaging software.
ImekaTM imaging what matters
ImekaTM and ANDITM are trademarks of ImekaTM Solutions Inc. | © 2024 Imeka